EUVIMEDEUVIMED entdecken
Zurückgezogene PublikationOpen Access · CC BY 4.0

RETRACTED: Hidradenitis suppurativa and cardiovascular diseases: A bidirectional Mendelian randomization study

Ping Zhou iD, Xin Jiang, Dan Wang

Skin Research and Technology · 2024

DOI: 10.1111/srt.13853 ↗

Kurz gefasst

Zurückgezogene Publikation in der Zeitschrift Skin Research and Technology, 2024. Verfasst von Ping Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Medical College, Jiangxi University of Chinese Medicine, Nanchang, China. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Mendelian Randomization Analysis, Cardiovascular Diseases, Genome-Wide Association Study. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangxi Province, Jiangxi University of Chinese Medicine Science and Technology Innovation Team Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prior investigation has indicated a link between Hidradenitis suppurativa (HS) and cardiovascular diseases (CVDs), yet the causal relationship (CR) between these conditions remains unresolved.

Methods

This investigation utilized bidirectional Mendelian randomization (MR) analysis to determine the CR between HS and CVDs. Genetic instruments for both conditions were sourced from genome‐wide association studies (GWAS). The GWAS summary data for CVD comprised coronary artery disease (CAD), myocardial infarction (MI), coronary atherosclerosis (CA), ischemic stroke (IS), and chronic heart failure (CHF). Four new approaches were added to the inverse variance weighted (IVW) method for the main analysis: weighted median, weighted MR‐Egger, simple mode, and weighted mode. The validity of the causal conclusions was verified by sensitivity tests that included leave‐one‐out analysis, heterogeneity, and pleiotropy.

Results

HS and CAD (OR = 1.024; 95%CI: 1.002–1.046, P = 0.033), MI (OR = 1.001; 95%CI: 1.000–1.002, P = 0.033), and CA (OR = 1.001; 95%CI: 1.000–1.002, P = 0.022) were identified to have a positive CR, according to the IVW analysis. Conversely, no significant association was identified between HS and either IS or CHF. Furthermore, the bidirectional analysis indicated no reverse causation between these diseases.

Conclusion

The findings of this study suggest a potential CR between HS and CAD, MI, and CA. Additional research is warranted to elucidate the biological mechanisms underlying these associations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaMendelian Randomization AnalysisCardiovascular DiseasesGenome-Wide Association StudyHumansPolymorphism, Single Nucleotide

Stichwörter der Autor:innen

Mendelian randomizationcardiovascular diseasescausal relationshipgenehidradenitis suppurativa

Autor:innen und Institutionen

  • Clinical Medical College, Jiangxi University of Chinese Medicine, Nanchang, China.
  • Department of Dermatology, Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang, China.

ORCID-Profile: Ping Zhou

Förderung

  • Natural Science Foundation of Jiangxi Province
  • Jiangxi University of Chinese Medicine Science and Technology Innovation Team Development Program

Zitieren

APA

Zhou, P., Jiang, X., & Wang, D. (2024). RETRACTED: Hidradenitis suppurativa and cardiovascular diseases: A bidirectional Mendelian randomization study. Skin Research and Technology. https://doi.org/10.1111/srt.13853

Vancouver

Zhou P, Jiang X, Wang D. RETRACTED: Hidradenitis suppurativa and cardiovascular diseases: A bidirectional Mendelian randomization study. Skin Research and Technology. 2024. doi:10.1111/srt.13853

BibTeX
@article{Zhou2024,
  author = {Zhou, Ping and Jiang, Xin and Wang, Dan},
  title = {RETRACTED: Hidradenitis suppurativa and cardiovascular diseases: A bidirectional Mendelian randomization study},
  journal = {Skin Research and Technology},
  year = {2024},
  doi = {10.1111/srt.13853}
}
Kostenlos starten →